Pandey K, Pant S, Kanbara H, Shuaibu MN, Mallik AK, Pandey BD, Kaneko O, Yanagi T, 2008. Molecular detection of Leishmania parasites from whole bodies of sandflies collected in Nepal. Parasitol Res 108: 293–297.
World Health Organization, 2005. Regional technical advisory group on kala-azar elimination. Proceedings of the 1st Meeting, December 20–23, 2004; New Delhi, India.
Department of Health Sciences, 2007. Annual Report on Nepal. Kathmandu, Nepal, 145–148.
Rijal S, Chappuis F, Singh R, Bovier PA, Acharya P, Karki BM, Das ML, Desjues P, Loutan L, Koirala S, 2003. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stiboglucanate and need for the policy to limit further decline. Trans R Soc Trop Med Hyg 97: 350–354.
Joshi S, Bajracharya BL, Baral MR, 2006. Kala-azar (visceral leishmaniasis) from Khotang. Kathmandu Univ Med J 4: 232–234.
Park K, 2007. Leishmaniasis. Park K, ed. Park's Text Book of Preventive and Social Medicine, 6th ed. Jabalpur, India: Banarsidas Bhanot, 256–258.
Verma SK, Ahmed S, Shirazi N, Kusum A, Kaushik RM, Barthwal SP, 2007. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarkhand, India. Trans R Soc Trop Med Hyg 101: 730–732.
Mahajan SK, Machhan P, Kanga A, Thakur S, Sharma A, Prasher BS, Pal LS, 2004. Kala-azar at high altitude. J Commun Dis 36: 117–120.
Pandey BD, Pandey K, Kaneko O, Yanagi T, Hirayama K, 2009. Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient. Am J Trop Med Hyg 80: 580–582.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 424 | 391 | 79 |
Full Text Views | 378 | 15 | 1 |
PDF Downloads | 98 | 12 | 1 |
We report the first case of visceral leishmaniasis (VL) from the non-endemic western hilly region of Nepal. The patient presented with a history of high-grade fever, abdominal distension, anemia, and weight loss. The case was confirmed as VL by microscopical detection of the Leishmania species amastigote in bone marrow aspiration and by a positive result for the rK39 test. The patient was treated with 0.5–1.0 mg/kg of Amphotericin B for 14 days (total of 405 mg), and amastigotes were negative on discharge. Five months later, this patient again developed fever, abdominal distension, and anemia. Clinical and hematological examinations suggested a relapse of VL. The patient was treated with 1 mg/kg of Amphotericin B for 18 days (total of 515 mg) and was clinically improved on discharge.
Financial support: This study was supported in part by Grants-in-Aid from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Global Center of Excellence (COE) Program at Nagasaki University (to O.K. and K.H.), and the National Bio-Resource Project (NBRP) of MEXT, Japan (to K.H.).
Authors' addresses: Basu Dev Pandey and Sher Bahadur Pun, Sukraraj Tropical and Infectious Diseases Hospital and Everest International Clinic and Research Center, Kathmandu, Nepal, E-mails: basupandey@wlink.com.np and drsherbdr@yahoo.com. Osamu Kaneko, Department of Protozoology, Institute of Tropical Medicine (NEKKEN) and the Global Center of Excellence Program, Nagasaki University, Nagasaki, Japan, E-mail: okaneko@nagasaki-u.ac.jp. Kishor Pandey, Everest International Clinic and Research Center, Kathmandu, Nepal, E-mail: pandey_kishor@hotmail.com. Kenji Hirayama, Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN) and the Global Center of Excellence Program, Nagasaki University, Nagasaki, Japan, E-mail: hiraken@nagasaki-u.ac.jp.
Pandey K, Pant S, Kanbara H, Shuaibu MN, Mallik AK, Pandey BD, Kaneko O, Yanagi T, 2008. Molecular detection of Leishmania parasites from whole bodies of sandflies collected in Nepal. Parasitol Res 108: 293–297.
World Health Organization, 2005. Regional technical advisory group on kala-azar elimination. Proceedings of the 1st Meeting, December 20–23, 2004; New Delhi, India.
Department of Health Sciences, 2007. Annual Report on Nepal. Kathmandu, Nepal, 145–148.
Rijal S, Chappuis F, Singh R, Bovier PA, Acharya P, Karki BM, Das ML, Desjues P, Loutan L, Koirala S, 2003. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stiboglucanate and need for the policy to limit further decline. Trans R Soc Trop Med Hyg 97: 350–354.
Joshi S, Bajracharya BL, Baral MR, 2006. Kala-azar (visceral leishmaniasis) from Khotang. Kathmandu Univ Med J 4: 232–234.
Park K, 2007. Leishmaniasis. Park K, ed. Park's Text Book of Preventive and Social Medicine, 6th ed. Jabalpur, India: Banarsidas Bhanot, 256–258.
Verma SK, Ahmed S, Shirazi N, Kusum A, Kaushik RM, Barthwal SP, 2007. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarkhand, India. Trans R Soc Trop Med Hyg 101: 730–732.
Mahajan SK, Machhan P, Kanga A, Thakur S, Sharma A, Prasher BS, Pal LS, 2004. Kala-azar at high altitude. J Commun Dis 36: 117–120.
Pandey BD, Pandey K, Kaneko O, Yanagi T, Hirayama K, 2009. Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient. Am J Trop Med Hyg 80: 580–582.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 424 | 391 | 79 |
Full Text Views | 378 | 15 | 1 |
PDF Downloads | 98 | 12 | 1 |